12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

  • TG Therapeutics TGTX stock rose 57.5% to $8.13 during Thursday's regular session. Trading volume for TG Therapeutics's stock is 5.1 million as of 12:30 EST. This is 209.1% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 billion. As per the news, the Q3 earnings report came out today.
  • PetIQ PETQ shares moved upwards by 38.46% to $9.9. Trading volume for this security as of 12:30 EST is 973.5K, which is 157.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $290.1 million. As per the news, the Q3 earnings report came out yesterday.
  • BioLife Solns BLFS shares moved upwards by 36.53% to $23.62. As of 12:30 EST, BioLife Solns's stock is trading at a volume of 611.6K, which is 177.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q3 earnings came out yesterday.
  • ZimVie ZIMV shares moved upwards by 31.33% to $9.64. Trading volume for this security as of 12:30 EST is 493.1K, which is 145.6% of its average full-day volume over the last 100 days. The company's market cap stands at $251.4 million. The company's, Q3 earnings came out yesterday.
  • Invitae NVTA shares moved upwards by 29.38% to $2.95. As of 12:30 EST, Invitae's stock is trading at a volume of 14.8 million, which is 81.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $716.5 million. As per the news, the Q3 earnings report came out 2 days ago.
  • NanoString Technologies NSTG shares increased by 26.79% to $7.43. Trading volume for NanoString Technologies's stock is 1.4 million as of 12:30 EST. This is 147.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $346.5 million. As per the press release, Q3 earnings came out 3 days ago.

Losers

  • Apyx Medical APYX stock declined by 62.8% to $1.64 during Thursday's regular session. Trading volume for Apyx Medical's stock is 1.8 million as of 12:30 EST. This is 1390.0% of its average full-day volume over the last 100 days. The company's market cap stands at $56.6 million. The company's, Q3 earnings came out today.
  • Brainstorm Cell BCLI shares declined by 43.26% to $1.64. As of 12:30 EST, Brainstorm Cell's stock is trading at a volume of 1.6 million, which is 685.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $59.8 million.
  • Cano Health CANO shares fell 32.49% to $2.25. As of 12:30 EST, Cano Health's stock is trading at a volume of 21.7 million, which is 244.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $544.7 million. As per the press release, Q3 earnings came out yesterday.
  • Vigil Neuroscience VIGL shares fell 22.98% to $9.49. The market value of their outstanding shares is at $268.2 million. As per the press release, Q3 earnings came out today.
  • NeuroBo Pharmaceuticals NRBO shares fell 19.79% to $1.3. Trading volume for this security as of 12:30 EST is 5.1 million, which is 299.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 million.
  • Organogenesis Hldgs ORGO shares declined by 19.26% to $2.5. As of 12:30 EST, Organogenesis Hldgs's stock is trading at a volume of 1.3 million, which is 140.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $326.5 million. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!